Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™’s Efficacy; Analysts Reiterate Buy Ratings

An incredible amount of planning and preparation goes into the design of…

South Pacific Metals Expanding Significant Copper-Gold Project

South Pacific Metals (TSX-V: SPMC) (OTCQB: SPMEF) does not have a scale…